Srishti Gurnani
About Srishti Gurnani
Srishti Gurnani is a Senior Research Associate at LifeMine Therapeutics, where she delivers biological assay data to optimize lead molecules and contributes to early discovery stage programs in Oncology. She holds a PhD in Molecular Pharmacology from the University of Liverpool and has extensive experience in various research roles across multiple institutions.
Work at LifeMine Therapeutics
Srishti Gurnani serves as a Senior Research Associate at LifeMine Therapeutics, a position she has held since 2018. In this role, she delivers high-quality biological assay data to the Medicinal Chemistry group and other functional teams, focusing on optimizing promising lead molecules. She independently contributes to the Cell Biology team, working on multiple early discovery stage targets within the Oncology Therapeutic area. Her responsibilities include developing robust, cell-based assays to profile the potency and mechanism of action of novel molecules.
Education and Expertise
Srishti Gurnani has a strong educational background in the life sciences. She earned a Bachelor of Science (BSc) in Molecular Biology from the University of Toronto at Mississauga - Erindale College, completing her studies from 2007 to 2011. She then pursued a Master of Science (MS) in Biotechnology at Northeastern University, graduating in 2014. Currently, she is working towards a Doctor of Philosophy (PhD) in Molecular Pharmacology at the University of Liverpool, expected to complete in 2024.
Professional Background
Srishti Gurnani has accumulated diverse experience in various research roles. Prior to her current position, she worked as a Senior Research Associate at Momenta Pharmaceuticals from 2014 to 2018. Her earlier roles include being a Research Assistant at Northeastern University in 2013, a Clinical Laboratory Technician at PRACS Institute from 2011 to 2012, and a Laboratory Assistant in the Behavioral Genetics Lab at the University of Toronto from 2010 to 2011. Additionally, she served as a Biochemistry Lab Analyst at Lambda Therapeutic Research in 2011 and as a Clinical Research Coordinator Associate at PRACS Institute in 2012.
Research Contributions
In her current role, Srishti Gurnani develops stable cell lines using CRISPR knockout and overexpression techniques, which are utilized in cell-based assays and for creating disease-relevant cell models. She organizes and presents experimental results to her team, ensuring that clear experimental records are maintained. Her work significantly contributes to the understanding of cellular mechanisms in the context of oncology.